SUBJECT INDEX 



599 



Tuberculosis— Continued. 



and our livestock industry, (40) 681. 



and pearl disease, (30) 582. 



antigen for, (C9) 583; (38) 786. 



antigen for complement fixation, (36) 81. 



as affected by organ extracts, (26) 484. 



atypical, in slaughtered animals, (20) 882. 



avian — 



and mammal, relationship, (26) 178. 

 blood picture in, (29) 285. 

 diagnosis, (30) 381; (34) 880; (36) 480. 

 etiology and control, (33) 389. 

 growth nn<i virulence of causative organ- 

 isms, (30) 482. 

 immunization, (36) S81. 

 in mammals, (26) 583. 

 in pigs, (33) 282, 283; (34) 277. 

 in swine. (40) 185. 

 notes, (27) 181, 381; (29) 273: (32) 480, 585, 781; 



(35) 576, 786; (36) 179. 

 studips, (27) 686; (28) 476, 883; (31) 581, 582. 

 transmission to hogs, (31) 683. 

 transmission to man, (31) 581. 

 biochemistry and chemotherapy, (28) 584; (2i0 

 177; (30) 80; (33) 481, 482, 677, 877; (35) 181; (39) 

 685. 

 blood transfusion in treatment, (40) 385. 

 bovine, (39) 582, 679. 

 bovine — 



and porcine, virulence of apparently sound 



tissue in, (37) 583. 

 causes, (26) 178. 



continuous temperature records, (36) 82. 

 control, (27) 286; (38) 687, 887. 

 bovine, control in — 

 Colorado, (32) 581. 

 dairy herds, (38) 81. 

 Germany, (27) 482. 

 Great Britain, (30) 382. 

 Hawaii, (34) 477; (39) 679. 

 Minnesota, (38) 282. 

 bovine — 



cycle, (27) 83. 



detecting, (26) 583; (40) 782. 

 diagnosis, (26) 484. 679; (27) 184, 286, 382, 482; 

 (28) 380, 679; (29) 178. 885; (301 883; (31) 

 379; (33) 387, 481; (35) 74; (36) 579; (37) 80; 

 (38) 887. 

 eariv stages, (29) 286. 



eradication, (29) 78, 286, 287; (30) 273, .38.'^; 

 (32) 780; (33) 85; (37) 379; (38) 82, 380, 686. 

 frequency, (26) 178. 



immunization, (28) 180; (29) 384, 480, 499, 

 884; (30) 482; (31) 85, 779; (32) 679; (34) 185, 

 575, 581, 678; (38) 81. 

 in Argentina, (40) 86. 



children, (34) 678; (37) 782. 

 Hawaii, (37) 374. 

 horses, (37) 378. 

 Illinois, (34) 185. 

 man, (37) 879. 

 Queensland, (38) 182. 

 the Punjab, (29) 491. 

 increasing resistance to, (34) 478. 

 infectiousness, (31) 284. 

 intradermal test for, (34) 185. 

 investigations, (26) 887; (27) 82; (29) 178; (31) 



881. 

 nature and treatment, (28) 585. 

 New York commission on, (31) 498. 

 notes, (27; 682, 885; (29) 79; (30) 381; (31) 80; 



(36; 81. 

 notes and treatment, (28) 679. 

 nurse cow factor, (38) 179. 

 phvsical examination and clinical diagnosis, 



(34) 184. 

 prevention, (29) 886. 

 prophylaxis in, (26) 485. 

 serous, (33) 282. 



spread among farm animals, (34) 678. 

 studies, (36) 579; (40) 86. 

 transmission- by swine, (38) 684. 

 transmission to man, (28) 375, 585. 780; (30) 



382, 581; (31) 285, 779; (32) 271; (33) 85. 

 transmission to offspring, (33) 278. 

 treatise, (28) 883; (30) 82; (38) 286. 

 treatment, (29) 384; (32) 182. 

 canine and human, relation, (35) 181. 

 caseation in, (32) 274. 

 cause and eradication, (29) 179. 



Tuberculosis— Continued. 



caused by inhalation, (30) 381; (32) 181, 274. 

 causes of, treatise, (39) 890. 

 chemotherapy, (29) 481 ; (36) 278, 279; (37) 379. 

 complement fixation in, (28) 885; (39) 82; (40) 



4S1 , 886. 8S7. 

 complement-fixing antibodies in, (31) 882; (32) 



181. 

 control, (39) 288, 390, 582, 679, 862; (40) 380, 577, 



681, 778. 

 control by milk commissions, (38) 381. 

 control in — 



Belgium, (26) 378. 

 England, (36) 275. 

 France, (27) 885. 

 Germany, (27) 784. 

 Michigan, (37) 274. 

 Norway, (33) 85. 

 Oregon, (37) 374. 

 Pennsylvania, (37) 577. 

 Sweden, (28) 781. 

 Wisconsin, (32) 275. 

 cutaneous, in man, (28) 180. 

 delayed or latent infection, (37) 378. 

 diagnosis, (26) 85, 180, 181, 283, 284, 379, 578, 

 582, 783; (27) 480, 481, 580, 681, 784, 885; (28) 

 284, 377; (29) 285, 382, 583; (30) 482; (31) 181, 

 379, 481, 878, 880; (32) 179, 181, 183, 376, 878; 

 (34) 81; (35) 575; (36) 181, 278, 676, 881; (40) 680i 

 diagnosis — 



complement-fixation test, (37) 180, 481. 

 intrapalpebral test, (36) 579, 779. 

 of open cases, (38) 179. 

 disease resembling in guinea pigs, (39) 686. 

 effect on — 



chemical composition of the animal body, 



(35) 883. 

 opsonins in healthy rabbits, (26) 180. 

 organs and tissues of rabbits, (28) 280. 

 equine — 



description, (26) 282. 

 investigations, (29) 385. 

 notes, (38) 4SG. 

 symtomatology, (29) 479. 

 eradication, (27) 77, 382, 475, 482. 576; (31) 380, 



676, 882. 

 eradication from cattle and swine, (38) 686. 

 eradication from herds, (29) 500, 886. 

 experimental epidemiology in, (36) 81. 

 fallacies in royal commission report, (28) 679. 

 hemolytic reactions in, (26) 379. 

 human and bovine — 



differentiation, (26) 281. 

 method of infection, (26) 484. 

 relation, (2fi) 886; (27) 381, 480, 784; (29) 479, 

 884; (30) 882; (31) 182, 670; (35) 75, 181; 

 (37) 80, 181. 

 human — 



bone and joint, (37) 181. 

 bovine, and avian, relation, (31) 581. 

 control, (29) 382. 

 control in England, (31) 779. 

 forms of, (26) 680. 

 immunization, (29) 884. 

 investigations, (26) 884. 

 transmission to bovines, (26) 378. 

 types of bacilli in, (35) 576. 

 immune blood transfusion for, (40) 385. 

 immunity, review of investigations, (28) 180. 

 immunity studies, (33) 480. 

 immunity to, (26) 181. 



immunization, (26) 181, 284, 379, 380, 578, 584, 

 676, 680, 681; (27) 184, 383, 482, 682; (28) 180, 

 585, 680; (29) 79, 481, 584, 782, 886; (30) 582, 

 782: (31) 380; (32) 182, 183, 276, 375; (33) 181, 

 284, 481, 878; (34) 274; (36) 883; (37) 880. 

 immunization, review, (26) 85. 

 immunization, treatise, (36) 182 

 in a rat, (39) 390. 

 animals, (30) 581. 

 asses, (34) 82. 

 camels, (37) 690; (40) 86. 

 camels, treatment, (29) 676. 

 carnivorous animals, (37) 880. 

 cattle and swine, (39) 390. 

 children and infants, (32) 878; (40) 584. 

 children, types of bacilli in, (29) 286. 

 dogs, (26) 85; (40) 782. 

 dogs and cats, (.35) 75. 

 East Indian buffaloes, (26) 378. 



